Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Sakai

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Journal of Diabetes Investigation|December 30, 2020
Sodium-glucose cotransporter 2 inhibitor-induced reduction in the mean arterial pressure improved renal composite outcomes in type 2 diabetes mellitus patients with chronic kidney disease: A propensity score-matched model analysis in JapanKazuo Kobayashi, Masao Toyoda, Nobuo Hatori, et al.
Thyroid Research|October 2, 2022
Ventricular fibrillation immediately after the treatment of Graves' disease coexisting with atypical angina and long QT syndrome: a case reportHajime Iwasaki, Hirotsugu Suwanai, Hiroyuki Sakai, et al.
Journal of Cardiology|September 15, 2022
Long-term outcome and risk factors associated with events in patients with atrial fibrillation treated with oral anticoagulants: The ASSAF-K registryYutaka Hatori, Hiroyuki Sakai, Nobuo Hatori, et al.
Scientific Reports|September 28, 2022
Comparison of the blood pressure management between sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonistsKazuo Kobayashi, Masao Toyoda, Nobuo Hatori, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 21, 2020
The influence of long-term administration of SGLT2 inhibitors on blood pressure at the office and at home in patients with type 2 diabetes mellitus and chronic kidney diseaseTakayuki Furuki, Kazuo Kobayashi, Masao Toyoda, et al.
Plos One|October 2, 2015
Correlation between Serum Levels of 3,3',5'-Triiodothyronine and Thyroid Hormones Measured by Liquid Chromatography-Tandem Mass Spectrometry and ImmunoassayHiroyuki Sakai, Hidenori Nagao, Mamoru Sakurai, et al.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|November 29, 2016
A Survey of Actual Clinical Practice Concerning Blood Pressure Control among Patients with Hypertension in Kanagawa 2014Nobuo Hatori, Hiroyuki Sakai, Kazuyoshi Sato, et al.
Internal Medicine (Tokyo, Japan)|July 14, 2012
Usefulness and limitations of unilateral adrenalectomy for ACTH-independent macronodular adrenal hyperplasia in a patient with poor glycemic controlTakaaki Kobayashi, Takashi Miwa, Kenshi Kan, et al.
Plos One|July 9, 2016
Correction: Correlation between Serum Levels of 3,3',5'-Triiodothyronine and Thyroid Hormones Measured by Liquid Chromatography-Tandem Mass Spectrometry and ImmunoassayHiroyuki Sakai, Hidenori Nagao, Mamoru Sakurai, et al.
Journal of Clinical Medicine Research|February 10, 2017
Primary Care-Based Investigation of the Effect of Sitagliptin on Blood Pressure in Hypertensive Patients With Type 2 DiabetesShouhei Yuasa, Kazuyoshi Sato, Takamoto Furuki, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Journal of Diabetes Investigation|December 30, 2020
Sodium-glucose cotransporter 2 inhibitor-induced reduction in the mean arterial pressure improved renal composite outcomes in type 2 diabetes mellitus patients with chronic kidney disease: A propensity score-matched model analysis in JapanKazuo Kobayashi, Masao Toyoda, Nobuo Hatori, et al.
Thyroid Research|October 2, 2022
Ventricular fibrillation immediately after the treatment of Graves' disease coexisting with atypical angina and long QT syndrome: a case reportHajime Iwasaki, Hirotsugu Suwanai, Hiroyuki Sakai, et al.
Journal of Cardiology|September 15, 2022
Long-term outcome and risk factors associated with events in patients with atrial fibrillation treated with oral anticoagulants: The ASSAF-K registryYutaka Hatori, Hiroyuki Sakai, Nobuo Hatori, et al.
Scientific Reports|September 28, 2022
Comparison of the blood pressure management between sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonistsKazuo Kobayashi, Masao Toyoda, Nobuo Hatori, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 21, 2020
The influence of long-term administration of SGLT2 inhibitors on blood pressure at the office and at home in patients with type 2 diabetes mellitus and chronic kidney diseaseTakayuki Furuki, Kazuo Kobayashi, Masao Toyoda, et al.
Plos One|October 2, 2015
Correlation between Serum Levels of 3,3',5'-Triiodothyronine and Thyroid Hormones Measured by Liquid Chromatography-Tandem Mass Spectrometry and ImmunoassayHiroyuki Sakai, Hidenori Nagao, Mamoru Sakurai, et al.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|November 29, 2016
A Survey of Actual Clinical Practice Concerning Blood Pressure Control among Patients with Hypertension in Kanagawa 2014Nobuo Hatori, Hiroyuki Sakai, Kazuyoshi Sato, et al.
Internal Medicine (Tokyo, Japan)|July 14, 2012
Usefulness and limitations of unilateral adrenalectomy for ACTH-independent macronodular adrenal hyperplasia in a patient with poor glycemic controlTakaaki Kobayashi, Takashi Miwa, Kenshi Kan, et al.
Plos One|July 9, 2016
Correction: Correlation between Serum Levels of 3,3',5'-Triiodothyronine and Thyroid Hormones Measured by Liquid Chromatography-Tandem Mass Spectrometry and ImmunoassayHiroyuki Sakai, Hidenori Nagao, Mamoru Sakurai, et al.
Journal of Clinical Medicine Research|February 10, 2017
Primary Care-Based Investigation of the Effect of Sitagliptin on Blood Pressure in Hypertensive Patients With Type 2 DiabetesShouhei Yuasa, Kazuyoshi Sato, Takamoto Furuki, et al.
Pageof 10